Tivozanib
Tivozanib
Tivozanib (pronounced tee-voe-ZAN-ib) is a type of cancer drug that is used to treat advanced renal cell carcinoma (RCC). It is a tyrosine kinase inhibitor that works by blocking certain proteins that can influence the growth and spread of cancer cells.
Etymology
The name "Tivozanib" is derived from the combination of the words "tyrosine", "vascular", and "inhibitor", which describe the drug's function. "Tyrosine" refers to the type of enzyme that the drug inhibits, "vascular" refers to the drug's effect on blood vessels, and "inhibitor" refers to the drug's ability to block or reduce a particular action or function.
Usage
Tivozanib is used to treat advanced renal cell carcinoma, a type of kidney cancer. It is usually given after other treatments have failed. The drug is taken orally, typically once a day for 21 days, followed by a 7-day break before the next cycle begins.
Side Effects
Common side effects of Tivozanib include fatigue, diarrhea, hypertension, nausea, and dysphonia. In rare cases, Tivozanib can cause serious side effects such as heart failure, liver problems, and bleeding.
Related Terms
External links
- Medical encyclopedia article on Tivozanib
- Wikipedia's article - Tivozanib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski